| John F Fiederlein, MD | |
|
1411 S Creasy Ln, Suite 130, Lafayette, IN 47905-7438 | |
| (765) 447-7447 | |
| (765) 807-0553 |
| Full Name | John F Fiederlein |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 33 Years |
| Location | 1411 S Creasy Ln, Lafayette, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689642779 | NPI | - | NPPES |
| 000000220414 | Other | IN | ANTHEM PROVIDER NUMBER |
| 200394920 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 01055952A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Indiana University Health Bloomington Hospital | Bloomington, IN | Hospital |
| Indiana University Health Paoli Hospital | Paoli, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Unity Healthcare Llc | 0244123362 | 76 |
| Southern Indiana Radiological Associates Inc | 3173415890 | 15 |
| Sira Imaging Center Llc | 3274425996 | 15 |
News Archive
A brain-computer interface (BCI) that translates electrical signals detected from the scalp into a user's commands offers comparable precision, speed and accuracy to systems that rely on electrodes surgically implanted in the brain, researchers at the Department of Health's Wadsworth Center laboratories have shown.
Social media often features celebrities drinking cocktails, boozy how-to posts, and party pictures. This is the environment American teens are immersed in every day, with 71 percent of teens using more than one social media site, spending an average of nine hours a day using media.
VIVUS, Inc. today announced that the company filed a Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) for QNEXA® (phentermine/topiramate) Controlled Release Capsules in the European Union (EU). The proposed indication in the EU is for the treatment of obesity, including weight loss and maintenance of weight loss, and should be used in conjunction with a mildly hypocaloric diet.
In the July 2018 issue of SLAS Discovery, a review article summarizes new methods of fragment-based lead discovery to identify new compounds as potential antibiotics.
Recent research from Houston Methodist Hospital showed that a new immunotherapy was safe for patients with ALS and also revealed surprising results that could bring hope to patients who have this relentlessly progressive and fatal disease.
› Verified 4 days ago
| Entity Name | Unity Healthcare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619929098 PECOS PAC ID: 0244123362 Enrollment ID: O20040203001083 |
News Archive
A brain-computer interface (BCI) that translates electrical signals detected from the scalp into a user's commands offers comparable precision, speed and accuracy to systems that rely on electrodes surgically implanted in the brain, researchers at the Department of Health's Wadsworth Center laboratories have shown.
Social media often features celebrities drinking cocktails, boozy how-to posts, and party pictures. This is the environment American teens are immersed in every day, with 71 percent of teens using more than one social media site, spending an average of nine hours a day using media.
VIVUS, Inc. today announced that the company filed a Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) for QNEXA® (phentermine/topiramate) Controlled Release Capsules in the European Union (EU). The proposed indication in the EU is for the treatment of obesity, including weight loss and maintenance of weight loss, and should be used in conjunction with a mildly hypocaloric diet.
In the July 2018 issue of SLAS Discovery, a review article summarizes new methods of fragment-based lead discovery to identify new compounds as potential antibiotics.
Recent research from Houston Methodist Hospital showed that a new immunotherapy was safe for patients with ALS and also revealed surprising results that could bring hope to patients who have this relentlessly progressive and fatal disease.
› Verified 4 days ago
| Entity Name | Sira Imaging Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558326124 PECOS PAC ID: 3274425996 Enrollment ID: O20040327000005 |
News Archive
A brain-computer interface (BCI) that translates electrical signals detected from the scalp into a user's commands offers comparable precision, speed and accuracy to systems that rely on electrodes surgically implanted in the brain, researchers at the Department of Health's Wadsworth Center laboratories have shown.
Social media often features celebrities drinking cocktails, boozy how-to posts, and party pictures. This is the environment American teens are immersed in every day, with 71 percent of teens using more than one social media site, spending an average of nine hours a day using media.
VIVUS, Inc. today announced that the company filed a Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) for QNEXA® (phentermine/topiramate) Controlled Release Capsules in the European Union (EU). The proposed indication in the EU is for the treatment of obesity, including weight loss and maintenance of weight loss, and should be used in conjunction with a mildly hypocaloric diet.
In the July 2018 issue of SLAS Discovery, a review article summarizes new methods of fragment-based lead discovery to identify new compounds as potential antibiotics.
Recent research from Houston Methodist Hospital showed that a new immunotherapy was safe for patients with ALS and also revealed surprising results that could bring hope to patients who have this relentlessly progressive and fatal disease.
› Verified 4 days ago
| Entity Name | Indiana University Radiology Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336192665 PECOS PAC ID: 7315922267 Enrollment ID: O20040623001054 |
News Archive
A brain-computer interface (BCI) that translates electrical signals detected from the scalp into a user's commands offers comparable precision, speed and accuracy to systems that rely on electrodes surgically implanted in the brain, researchers at the Department of Health's Wadsworth Center laboratories have shown.
Social media often features celebrities drinking cocktails, boozy how-to posts, and party pictures. This is the environment American teens are immersed in every day, with 71 percent of teens using more than one social media site, spending an average of nine hours a day using media.
VIVUS, Inc. today announced that the company filed a Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) for QNEXA® (phentermine/topiramate) Controlled Release Capsules in the European Union (EU). The proposed indication in the EU is for the treatment of obesity, including weight loss and maintenance of weight loss, and should be used in conjunction with a mildly hypocaloric diet.
In the July 2018 issue of SLAS Discovery, a review article summarizes new methods of fragment-based lead discovery to identify new compounds as potential antibiotics.
Recent research from Houston Methodist Hospital showed that a new immunotherapy was safe for patients with ALS and also revealed surprising results that could bring hope to patients who have this relentlessly progressive and fatal disease.
› Verified 4 days ago
| Entity Name | Southern Indiana Radiological Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346205911 PECOS PAC ID: 3173415890 Enrollment ID: O20040719001304 |
News Archive
A brain-computer interface (BCI) that translates electrical signals detected from the scalp into a user's commands offers comparable precision, speed and accuracy to systems that rely on electrodes surgically implanted in the brain, researchers at the Department of Health's Wadsworth Center laboratories have shown.
Social media often features celebrities drinking cocktails, boozy how-to posts, and party pictures. This is the environment American teens are immersed in every day, with 71 percent of teens using more than one social media site, spending an average of nine hours a day using media.
VIVUS, Inc. today announced that the company filed a Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) for QNEXA® (phentermine/topiramate) Controlled Release Capsules in the European Union (EU). The proposed indication in the EU is for the treatment of obesity, including weight loss and maintenance of weight loss, and should be used in conjunction with a mildly hypocaloric diet.
In the July 2018 issue of SLAS Discovery, a review article summarizes new methods of fragment-based lead discovery to identify new compounds as potential antibiotics.
Recent research from Houston Methodist Hospital showed that a new immunotherapy was safe for patients with ALS and also revealed surprising results that could bring hope to patients who have this relentlessly progressive and fatal disease.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John F Fiederlein, MD Po Box 4699, Lafayette, IN 47903-4699 Ph: (765) 449-2732 | John F Fiederlein, MD 1411 S Creasy Ln, Suite 130, Lafayette, IN 47905-7438 Ph: (765) 447-7447 |
News Archive
A brain-computer interface (BCI) that translates electrical signals detected from the scalp into a user's commands offers comparable precision, speed and accuracy to systems that rely on electrodes surgically implanted in the brain, researchers at the Department of Health's Wadsworth Center laboratories have shown.
Social media often features celebrities drinking cocktails, boozy how-to posts, and party pictures. This is the environment American teens are immersed in every day, with 71 percent of teens using more than one social media site, spending an average of nine hours a day using media.
VIVUS, Inc. today announced that the company filed a Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) for QNEXA® (phentermine/topiramate) Controlled Release Capsules in the European Union (EU). The proposed indication in the EU is for the treatment of obesity, including weight loss and maintenance of weight loss, and should be used in conjunction with a mildly hypocaloric diet.
In the July 2018 issue of SLAS Discovery, a review article summarizes new methods of fragment-based lead discovery to identify new compounds as potential antibiotics.
Recent research from Houston Methodist Hospital showed that a new immunotherapy was safe for patients with ALS and also revealed surprising results that could bring hope to patients who have this relentlessly progressive and fatal disease.
› Verified 4 days ago
Katharine L Krol, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2403 Loy Dr, Lafayette, IN 47909 Phone: 765-448-8000 Fax: 765-446-4351 | |
Rodney A Dunseath, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 2403 Loy Dr, Lafayette, IN 47909 Phone: 765-448-8000 Fax: 765-446-4351 | |
Mark Curtis Arvin, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5165 Mccarty Ln, Lafayette, IN 47905 Phone: 765-448-8000 | |
Matthew Orton, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 420 N 26th St, Lafayette, IN 47904 Phone: 765-448-8000 Fax: 765-448-7599 | |
Erika J Ugianskis, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2600 Greenbush St, Lafayette, IN 47904 Phone: 765-448-8000 | |
Bedatri Sinha, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1425 Unity Pl, Lafayette, IN 47905 Phone: 765-447-7460 Fax: 765-447-8396 | |
Peter Simmons, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1411 S Creasy Ln, Suite 130, Lafayette, IN 47905 Phone: 765-447-7447 Fax: 765-447-1767 |